tiprankstipranks
HAVN Life Sciences (TSE:HAVN)
:HAVN

HAVN Life Sciences (HAVN) Price & Analysis

13 Followers

HAVN Stock Chart & Stats

C$0.03
C$0.00(0.00%)
At close: 4:00 PM EDT
C$0.03
C$0.00(0.00%)

HAVN FAQ

What was HAVN Life Sciences’s price range in the past 12 months?
HAVN Life Sciences lowest stock price was C$0.03 and its highest was C$0.03 in the past 12 months.
    What is HAVN Life Sciences’s market cap?
    HAVN Life Sciences’s market cap is C$769.38K.
      When is HAVN Life Sciences’s upcoming earnings report date?
      The company’s upcoming earnings report date is not yet available.
      How were HAVN Life Sciences’s earnings last quarter?
      Currently, no data Available
      Is HAVN Life Sciences overvalued?
      According to Wall Street analysts HAVN Life Sciences’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
        Does HAVN Life Sciences pay dividends?
        HAVN Life Sciences does not currently pay dividends.
        What is HAVN Life Sciences’s EPS estimate?
        HAVN Life Sciences’s EPS estimate for its next earnings report is not yet available.
        How many shares outstanding does HAVN Life Sciences have?
        HAVN Life Sciences has 25,646,020 shares outstanding.
          What happened to HAVN Life Sciences’s price movement after its last earnings report?
          Currently, no data Available
          Which hedge fund is a major shareholder of HAVN Life Sciences?
          Currently, no hedge funds are holding shares in TSE:HAVN
          What is the TipRanks Smart Score and how is it calculated?
          Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

            Company Description

            HAVN Life Sciences

            HAVN Life Sciences Inc. is a biotechnology firm dedicated to the research and creation of psychotropic compounds sourced from flora and fungi. The company's expertise includes devising standardized and quality-assured extraction techniques for psychoactive substances, particularly from Psilocybe mushrooms, to isolate key compounds such as psilocybin, psilocin, and baeocystin. Furthermore, it develops natural health remedies using non-regulated ingredients. This Canadian company, founded in 2020, is headquartered in Richmond.

            HAVN Life Sciences (HAVN) Earnings & Revenues

            Similar Stocks
            Company
            Price & Change
            Follow
            MYND Life Sciences
            Universal Ibogaine Inc
            Mindbio Therapeutics Corp.
            Popular Stocks